Related Experiment Video
Updated: Jun 23, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Hypertension in dialysis and kidney transplant patients
G V Ramesh Prasad1, Marcel Ruzicka, Kevin D Burns
1Division of Nephrology, St Michael's Hospital, University of Toronto, Toronto, Canada.
Insights
The Canadian Hypertension Education Program recommends blood pressure targets for patients with end-stage kidney disease on renal replacement therapy. Hypertensive patients on dialysis should aim for below 140/90 mmHg, and transplant patients below 130/80 mmHg.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Management
Background:
- Growing prevalence of end-stage kidney disease (ESKD) in Canada, with over 33,000 individuals requiring renal replacement therapy.
- Increasing likelihood of primary care practitioners managing complex ESKD patients on dialysis or with kidney transplants.
- Limited large-scale controlled clinical trials for blood pressure management in ESKD patients.
Purpose of the Study:
- To evaluate evidence for blood pressure control in patients undergoing renal replacement therapy.
- To establish consensus recommendations for managing hypertension in ESKD patients.
- To provide guidance for primary care practitioners managing these complex patients.
Main Methods:
- Systematic review and interpretation of existing literature.
- Consensus-based recommendation development by the Canadian Hypertension Education Program.
- Analysis of data from the Canadian Organ Replacement Registry.
Main Results:
- Recommended blood pressure target below 140/90 mmHg for hypertensive patients on renal replacement therapy (dialysis).
- Recommended blood pressure target below 130/80 mmHg for renal transplant patients, especially those with diabetes or chronic kidney disease.
- Evidence synthesis to guide clinical practice in a growing patient population.
Conclusions:
- Optimizing blood pressure control is crucial for patients with end-stage kidney disease on renal replacement therapy.
- Specific targets are recommended based on treatment modality (dialysis vs. transplant) and comorbidities.
- These guidelines aim to support primary care practitioners in managing hypertension in complex ESKD patients.
Abstract:
For the first time, the Canadian Hypertension Education Program has studied the evidence supporting blood pressure control in people requiring renal replacement therapy for end-stage kidney disease, including those on dialysis and with renal transplants. According to the Canadian Organ Replacement Registry's 2008 annual report, there were an estimated 33,832 people with end-stage renal disease in Canada at the end of 2006, an increase of 69.7% since 1997. Of these, 20,465 were on dialysis and 13,367 were living with a functioning kidney transplant. Thus, it is becoming more likely that primary care practitioners will be helping to care for these complex patients. With the lack of large controlled clinical trials, the consensus recommendation based on interpretation of the existing literature is that blood pressure should be lowered to below 140/90 mmHg in hypertensive patients on renal replacement therapy and to below 130/80 mmHg for renal transplant patients with diabetes or chronic kidney disease.
Related Concept Videos
Kidney Transplant III: Nursing Management
Hypertension and Regulation of Blood Pressure
Chronic Kidney Disease III: Interprofessional Care
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Hemodialysis II: Procedure and Complications
Kidney Transplant I: Introduction
